Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

タンパク質結合と抗生物質の濃度

R Wise, A P Gillett, B Cadge

    Lancet (London, England)
    |August 19, 1978
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Cochlear implantation in a profoundly deaf patient with MELAS syndrome.

    Journal of neurology, neurosurgery, and psychiatry·2001
    Same author

    Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.

    Arthritis and rheumatism·1999
    Same author

    Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration.

    Antimicrobial agents and chemotherapy·1999
    Same author

    Ten years of ciprofloxacin: the past, present and future. Pharmacokinetics. Introduction.

    The Journal of antimicrobial chemotherapy·1999
    Same author

    A review of the mechanisms of action and resistance of antimicrobial agents.

    Canadian respiratory journal·1999
    Same author

    The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.

    The Journal of antimicrobial chemotherapy·1999
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る